search for books and compare prices
schizophrenia chemotherapy matches 16 work(s)
displaying 1 to 16 | at end
show results in order: alphabetically | oldest to newest | newest to oldest
Cover for 9789048185528 Cover for 9789400799745 Cover for 9780470322826 Cover for 9780195388015 Cover for 9783805595117 Cover for 9783805595117 Cover for 9780123737373 Cover for 9780781724227 Cover for 9780880487856 Cover for 9780824793029 Cover for 9780471952879 Cover for 9780716721963 Cover for 9780716708988
cover image for 9789400799745
Product Description: Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms...read more
By Michael S. Ritsner (editor)

Hardcover:

9789048185528 | Springer Verlag, August 30, 2010, cover price $339.00 | About this edition: Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms.

Paperback:

9789400799745 | 1 edition (Springer Verlag, November 4, 2014), cover price $339.00 | About this edition: Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms.

cover image for 9780470322826
Product Description: New and emerging directions in pharmaceutical research to better treat schizophrenia Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease...read more
By Michael W. Wood (editor)

Hardcover:

9780470322826 | 1 edition (John Wiley & Sons Inc, July 10, 2012), cover price $193.00 | About this edition: New and emerging directions in pharmaceutical research to better treat schizophrenia Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease.

cover image for 9783805595117
Product Description: The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment...read more

Hardcover:

9783805595117 | 1 edition (S Karger Pub, July 29, 2010), cover price $87.00 | also contains Therapy-Resistant Schizophrenia | About this edition: The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine.

cover image for 9783805595117
Product Description: The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment...read more
By Helio Elkis (editor) and Herbert Y. Meltzer (editor)

Hardcover:

9783805595117 | 1 edition (S Karger Pub, July 29, 2010), cover price $87.00 | also contains Therapy-Resistant Schizophrenia | About this edition: The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine.

Hardcover:

9780521895330, titled "Antipsychotic Drugs in Schizophrenia: The Catie Project" | 1 edition (Cambridge Univ Pr, May 24, 2010), cover price $180.00

cover image for 9780123737373
By Anissa Abi-dargham (editor) and Olivier Guillin (editor)

Hardcover:

9780123737373 | 1 edition (Academic Pr, February 27, 2007), cover price $240.00

cover image for 9780781724227
Product Description: This text presents a broad-based review of the contemporary field of drugs for schizophrenia and is intended for graduate and postgraduate students and mental health professionals. It consists of 34 chapters by well-known experts in the field addressing basic mechanisms in the pathophysiology of schizophrenia, neuropharmacology, experimental strategies, atypical antipsychotics, and other clinical issue...read more (view table of contents, read Amazon.com's description)
By Alan Breier (editor)

Hardcover:

9780781724227 | Lippincott Williams & Wilkins, May 1, 2001, cover price $59.95 | About this edition: This text presents a broad-based review of the contemporary field of drugs for schizophrenia and is intended for graduate and postgraduate students and mental health professionals.

cover image for 9780880487856
Product Description: For the first time in a single volume, distinguished experts address the complex issues -- issues rarely confronted in empirical studies of patients with schizophrenia -- and controversial research surrounding the assessment of negative symptoms and cognitive deficits in patients with schizophrenia...read more (view table of contents, read Amazon.com's description)
By Richard S. E. Keefe (editor) and J. P. McEvoy (editor)

Hardcover:

9780880487856 | Amer Psychiatric Pub Inc, January 1, 2001, cover price $82.00 | About this edition: For the first time in a single volume, distinguished experts address the complex issues -- issues rarely confronted in empirical studies of patients with schizophrenia -- and controversial research surrounding the assessment of negative symptoms and cognitive deficits in patients with schizophrenia.

By Alan Breier (editor)

Hardcover:

9780880484916 | Amer Psychiatric Pub Inc, May 1, 1996, cover price $83.00

cover image for 9780471952879
Product Description: Internationally renowned experts in schizophrenia present an up-to-date review of this disorder's biological rather than psychological origins. Surveys new drugs for its treatment which are directed at novel biochemical targets in the brain...read more (view table of contents, read Amazon.com's description)

Hardcover:

9780471952879 | John Wiley & Son Ltd, October 1, 1995, cover price $360.00 | About this edition: Internationally renowned experts in schizophrenia present an up-to-date review of this disorder's biological rather than psychological origins.

cover image for 9780716721963
Product Description: The authors begin with the basic principles of neuroscience, diagnoses of mental disorders, and the action of drugs in the brain. Through case studies and discussions of major research, they then describe the nature of such major mental illnesses as schizophrenia, mood disorders, and anxiety disorders, explaining what is known about the benefits, side effects, and limitations of various drug therapies...read more

Hardcover:

9780716721956 | Rev sub edition (W H Freeman & Co, September 1, 1991), cover price $29.95 | About this edition: The authors begin with the basic principles of neuroscience, diagnoses of mental disorders, and the action of drugs in the brain.

Paperback:

9780716721963 | W H Freeman & Co, September 1, 1991, cover price $22.95 | About this edition: The authors begin with the basic principles of neuroscience, diagnoses of mental disorders, and the action of drugs in the brain.

cover image for 9780716708988
Discusses research findings, clinical procedures, and theoretical bases for the application of orthomolecular principles to cases of schizophrenia, alcoholism, and drug addiction where perceptual dysfunction and chemical-nutritive brain imbalances are indicated. Bibliogs

Hardcover:

9780716708988 | W H Freeman & Co, June 1, 1973, cover price $44.95 | About this edition: Discusses research findings, clinical procedures, and theoretical bases for the application of orthomolecular principles to cases of schizophrenia, alcoholism, and drug addiction where perceptual dysfunction and chemical-nutritive brain imbalances are indicated.

displaying 1 to 16 | at end